Condition
Monkeypox clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Monkeypox clinical trials that are recruiting, at sites in 5 countries (most in China (2), Brazil (1), France (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 5Countries
Newest Monkeypox clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safety, tolerability, and how the body processes BSY001 after single and multiple doses | Phase 1 | Hangzhou | Recruiting | Jan 29, 2026 |
| Evaluating the long-term effects of a booster dose of MVA-BN vaccine for monkeypox | — | Paris, Paris | Recruiting | Mar 20, 2025 |
| Two-dose MVA monkeypox live vaccine in adults | Phase 1 | Zhengzhou, Henan | Recruiting | Jan 13, 2025 |
| Follow-up of monkeypox cases and smallpox vaccine recipients | — | Antwerp | Recruiting | May 30, 2023 |
| Observational study of monkeypox infection in Brazil | — | Belém, Pará and 2 other locations | Recruiting | Mar 24, 2023 |
| Understanding immune responses to monkeypox vaccination in high-risk individuals | — | Badalona, Barcelona and 2 other locations | Recruiting | Sep 30, 2022 |
All recruiting trials (6)
-
Safety, tolerability, and how the body processes BSY001 after single and multiple doses
This trial will test whether BSY001 is safe, well tolerated, and how it is absorbed and cleared when given once or multiple times to healthy adults aged 18–50.
-
Evaluating the long-term effects of a booster dose of MVA-BN vaccine for monkeypox
This study is testing how well a booster dose of the MVA-BN vaccine works over time in men over 18 who have already had two doses to help protect against monkeypox.
-
Two-dose MVA monkeypox live vaccine in adults
This trial will test whether two doses of an MVA-strain monkeypox live vaccine are safe and produce an immune response in adults, including healthy people, men who have sex with men, and people living with HIV.
-
Follow-up of monkeypox cases and smallpox vaccine recipients
This project will follow adults who had monkeypox and people who received smallpox vaccine doses to see if immune responses remain strong over time and if any lasting physical or psychological effects develop.
-
Observational study of monkeypox infection in Brazil
This study is trying to see how different health factors affect the risk and severity of monkeypox in people in Brazil.
-
Understanding immune responses to monkeypox vaccination in high-risk individuals
This study is trying to see how well the monkeypox vaccine works in people at high risk, including those living with HIV, by looking at their immune responses after getting vaccinated.
Related topics
Quick answers
How many Monkeypox clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (2 trials), Brazil (1 trial), France (1 trial), Spain (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.